Bristol-Myers Squibb BMY
$62.14 +$0.00 (0.00%)
Pre-market · Nov 10, 7:50 am ET · After hours $62.43 +0.47%
Open$62.88
Prev close$62.14
Day range$61.80 – $63.06
Volume7.67M
Market cap$127.02B
P/E (TTM)13.8
Dividend yield4.06%
BMY Stock News
Headlines matching Bristol-Myers Squibb or the BMY ticker, most recent first.
- Wells Fargo Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $65
- Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Maintains Target Price $40
- Piper Sandler Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $82 Positive
- RBC Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $64
- HSBC Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $65 Positive
- J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $73
- Argus Research Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Announces Target Price $75 Positive
- Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $70 Positive
- BofA Securities Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $71
- Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating
- UBS Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $80
- Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $70
- William Blair Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating
- Barclays Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $75
- A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $65 to $80
No comments yet — be the first to weigh in on BMY.
Sign in to join the discussion.